BD and Ypsomed will expand their collaboration through the development of a 5.5 ml version of BD’s Neopak XtraFlow glass ...
Zacks Investment Research on MSN
BD and Ypsomed expand partnership to target growing biologics market
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its partnership with Ypsomed to ...
A new collaboration between Becton, Dickinson and Co. and Ypsomed will support the development of a 5.5-milliliter, glass, prefilled syringe designed for use with large-volume autoinjectors. The ...
The 5.5mL version of the BD Neopak XtraFlow syringe is fully compatible with Ypsomed’s YpsoMate 5.5 autoinjector platform.
The American College of Chest Physicians recently released a new clinical guideline on biologic management in severe asthma.
Learn how to administer self-injecting biologic medications with these simple and effective tips. If topical medications haven’t been strong enough to control your psoriasis, your dermatologist may ...
Treatment with biologic DMARDs vs standard therapy improved clinical response rates and flare outcomes among patients with polyarticular JIA.
Although biologics are usually given by injection or intravenous infusion, oral formulations might be possible. In general, oral drugs offer many benefits, from simplified distribution to overall cost ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Ypsomed, a leading developer of injection systems, are strengthening their collaboration with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback